Tandem Diabetes Care (TNDM) EPS (Basic) Growth (3y) (2016 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 117.17 Bn | 108.35 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 104.15 Bn | 100.67 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 63.37 Bn | 62.83 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.16 Bn | 30.22 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 20.74 Bn | 20.25 Bn | 684.20 Mn | 17.98% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 806.56 Mn | 144.78 Mn | 17.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.72% |
| Mar 31, 2026 | 46.22% |
| Dec 31, 2025 | 68.04% |
| Sep 30, 2025 | 25.71% |
| Jun 30, 2025 | -49.11% |
| Mar 31, 2025 | -104.39% |
| Dec 31, 2024 | -58.92% |
| Sep 30, 2024 | -80.68% |
| Jun 30, 2024 | -111.35% |
| Mar 31, 2024 | -100.30% |
| Dec 31, 2023 | -54.04% |
| Sep 30, 2023 | -48.87% |
| Jun 30, 2023 | -7.16% |
| Mar 31, 2023 | -97.43% |
| Dec 31, 2022 | -95.33% |
| Sep 30, 2022 | -149.07% |
| Jun 30, 2022 | -108.60% |
| Mar 31, 2022 | 16.66% |
| Dec 31, 2021 | 30.64% |
| Sep 30, 2021 | 29.02% |